ä¸çä¸ã§æ°åã³ããã¦ã¤ã«ã¹ã®å¤ç°æ ªã¨ã®æ¦ããç¶ãä¸ããã³ã°COVIDã¯ä¸çä¸ã®ä½ç¾ä¸äººãã®äººã ã®æ¥å¸¸çæ´»ã妨ãã¦ãã¾ããã¢ã¡ãªã«ã§ã¯æ人ã®13人ã«1人ãçã¿ãç²å´ãéåè½åã®ä½ä¸ã¨ãã£ããã³ã°COVIDã®çç¶ãçµé¨ãã¦ãããç§å¦è ãã¡ã¯ãã®çç¶ãåãããããã®è§£æ±ºçã模索ãã¦ããããã§ããã«ãªãã©ã«ãã¢å¤§å¦ããµã³ã¼ã«ã¹æ ¡(UCLA)ã®å»çæ©é¢ã§ããUCLA Healthã¨ãã¤ã©ã¼å»ç§å¤§å¦ã®ç 究ãã¼ã ã¯ããã³ã°COVIDã®ææ¸çã¨ãã¦ã¦ã§ã¢ã©ãã«ããã¤ã¹ã®ä½¿ç¨ãæ¤è¨ãã¦ãã¾ãã Transcutaneous electrical nerve stimulation for fibromyalgia-like syndrome in patients with Long-COVID: a pilot randomized clinical trial | Scientific Reports
{{#tags}}- {{label}}
{{/tags}}